Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Diagnostics & Research Medical Instruments & Supplies
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.


TSX:EDT - Post by User

Spectral Medical Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(284)
•••
  • BlueJays9293X
Comment by BlueJays9293on Sep 29, 2025 8:39pm
118 Views
Post# 36732146

RE:AIF

RE:AIF They needed to amend it because Board member, Jan D'Alvise, was the CEO of a small ($2.4 million) private company based in San Diego that went bankrupt, long before she joined Spectral's Board.  That company was trying to make a diagnostic blood test to detect autism but it failed its trial and went bust.  Sounds like she failed to disclose this and now Spectral has to amend things to state that she was formerly affiliated with a company that went bankrupt.  Just to be clear, this has absolutely nothing to do with Spectral, and its all on her for failing to disclose her past. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities